Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?

The Lancet

Volumn 346, Issue 8989, 1995, Pages 1504-1505

  Sandercock, Peter ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; ITALY; META ANALYSIS; MULTICENTER STUDY; NOTE; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; CEREBROVASCULAR DISORDERS; HUMANS; ITALY; META-ANALYSIS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY;

EID: 0029640562     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92044-7     Document Type: Article

References (9)

1. Large-scale randomised evidence: large, simple trials and overviews of trials
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity from all randomised trials of more than 1000 patients
3. Thrombolysis in acute ischaemic stroke
4. Termination of trial of streptokinase in severe acute ischaemic stroke
5. Trials of streptokinase in severe acute ischaemic stroke
6. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
7. The efficacy and safety of antiplatelet therapy in acute presumed ischaemic stroke: a systematic review of the randomised trials comparing antiplatelet therapy with control
8. Patient preferences for stroke outcomes
9. Treating acute stroke